Similar articles

• Biological and immunological activity of pancreatic glucagon and enteric glucagon-like immunoreactivity.

  Faloona GR, Unger RH. Faloona GR, et al. Isr J Med Sci. 1974 Oct;10(10):1324-31. Isr J Med Sci. 1974. PMID: 4611965 Review. No abstract available.
• Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with liver and fat cell plasma membranes: binding to specific sites and stimulation of adenylate cyclase.

  Bataille D, Freychet P, Rosselin G. Bataille D, et al. Endocrinology. 1974 Sep;95(3):713-21. doi: 10.1210/endo-95-3-713. Endocrinology. 1974. PMID: 4368831 No abstract available.
• Purification of canine gut glucagon-like immunoreactivity (GLI) and its insulin releasing activity.

  Ohneda A, Horigome K, Kai Y, Itabashi H, Ishii S, Yamagata S. Ohneda A, et al. Horm Metab Res. 1976 May;8(3):170-4. doi: 10.1055/s-0028-1093654. Horm Metab Res. 1976. PMID: 939462
• [Ca2+ inhibition of adenyl cyclase of rabbit jejunal mucosa].

  Iurkiv VA, Melikhov VI. Iurkiv VA, et al. Biull Eksp Biol Med. 1980 Oct;90(10):430-2. Biull Eksp Biol Med. 1980. PMID: 6252985 Russian.
• [Current problems in hormone research. 2. The role of receptors in some insulin effects at the cellular level].

  Heder G. Heder G. Pharmazie. 1974 Mar;29(3):153-9. Pharmazie. 1974. PMID: 4368099 Review. German. No abstract available.